SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CYNAPSUS THERAPEUTICS INC
(NQPK:CYNAF Last Sale: .43 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (CYNAF : $.43)
$17 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today
Toronto, ON, Research Report Earnings Snapshot - Last 11/11/18
Canada Annual Reports


Specialty pharmaceutical company developing the only non-injectable (i.e. sublingual) delivery of the only approved drug (apomorphine) to be used as a rescue therapy for “off” motor symptoms of Parkinson’s disease.
Historical Charts    Technical Analysis
No Historical Data available for CYNAF

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CYNAF $.43 $ 0 $.43 $.43 1,000 $.046 $.548 38,844
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $16,703

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex